Market closedNon-fractional

Nautilus Biotechnolgy/NAUT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Nautilus Biotechnolgy

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.

Ticker

NAUT

Sector

Healthcare

Trading on

NASDAQ

Industry

Life Sciences Tools and Services

Headquarters

Seattle, United States

Employees

163

NAUT Metrics

BasicAdvanced
$288M
Market cap
-
P/E ratio
-$0.54
EPS
1.00
Beta
-
Dividend rate
$288M
1
20.093
19.688
12.003
13.476
-15.70%
-24.38%
1.16
1.16
-4.972
17.66%
-3.17%

What the Analysts think about NAUT

Analyst Ratings

Majority rating from 4 analysts.
Buy

NAUT Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$19M
10.00%
Profit margin
0.00%
NaN%

NAUT Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 7.69%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.13
-$0.13
-$0.14
-$0.15
-
Expected
-$0.15
-$0.17
-$0.15
-$0.16
-$0.17
Surprise
-13.33%
-22.39%
-3.45%
-7.69%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Nautilus Biotechnolgy stock?

Nautilus Biotechnolgy (NAUT) has a market cap of $288M as of July 06, 2024.

What is the P/E ratio for Nautilus Biotechnolgy stock?

The price to earnings (P/E) ratio for Nautilus Biotechnolgy (NAUT) stock is 0 as of July 06, 2024.

Does Nautilus Biotechnolgy stock pay dividends?

No, Nautilus Biotechnolgy (NAUT) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Nautilus Biotechnolgy dividend payment date?

Nautilus Biotechnolgy (NAUT) stock does not pay dividends to its shareholders.

What is the beta indicator for Nautilus Biotechnolgy?

Nautilus Biotechnolgy (NAUT) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Nautilus Biotechnolgy stock

Buy or sell Nautilus Biotechnolgy stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing